{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T18:49:05Z","timestamp":1782240545587,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005774","name":"Universitat de Barcelona","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Orthop Trauma Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The strategy of debridement, antibiotics, and implant retention (DAIR) represents one of the main therapeutic modalities for acute periprosthetic joint infection (PJI). However, reported outcomes remain highly variable, with success rates ranging from 16 to 92%. This study aimed to evaluate long-term treatment failure-free survival and identify risk factors for treatment failure in patients with acute hip PJI treated with DAIR using time-to-event analytical methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and methods<\/jats:title>\n                    <jats:p>This retrospective study evaluated the treatment failure rate in 115 patients treated with the DAIR strategy for acute PJI following primary or aseptic revision hip arthroplasty between 1999 and 2018. Potential predictors of treatment failure-free survival, including patient characteristics, infection microbiology, and surgical timing, were analyzed using univariate tests, Cox proportional hazards regression (hazard ratio [HR]), and Kaplan\u2013Meier survival estimates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 115 patients included, 56 were women and 59 were men; 48 were aged 75 years or younger and 67 were older than 75 years. In 88 cases, the infection occurred after primary arthroplasty, whereas 27 followed aseptic revision surgery. The mean follow-up was 7.1 years (SD 4.4). At five years, treatment failure occurred in 30.4% of cases. Procedures performed within seven days of diagnosis showed lower failure rates than those after the first week following diagnosis (27.5% vs 53.8%, p\u2009=\u20090.05; HR\u2009=\u20092.09, 95% CI 0.91\u20134.79). Failure was more frequent after revision arthroplasty compared with primary arthroplasty (48.1% vs 25%, p\u2009=\u20090.02; HR\u2009=\u20092.15, 95% CI 1.08\u20134.27) and in polymicrobial infections compared with monomicrobial infections (47.8% vs 24.5%, p\u2009=\u20090.04; HR\u2009=\u20092.32, 95% CI 1.13\u20134.77). No other variables showed a significant association with failure risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Revision arthroplasty and polymicrobial infections were associated with higher failure rates after DAIR. Lower failure rates were observed among patients treated within seven days of diagnosis, although this finding should be interpreted with caution and warrants further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00402-026-06385-2","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T18:08:18Z","timestamp":1782238098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Timing and microbiological profile influence long-term outcomes after debridement, antibiotics, and implant retention (DAIR) in acute hip periprosthetic joint infection"],"prefix":"10.1007","volume":"146","author":[{"given":"Ernesto","family":"Mu\u00f1oz-Mahamud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Perdomo-Lizarraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Combalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Al\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e0","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenaro \u00c1ngel","family":"Fern\u00e1ndez-Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Verdejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lex","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"1","key":"6385_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jisako.2023.09.003","volume":"9","author":"UG Longo","year":"2024","unstructured":"Longo UG, De Salvatore S, Bandini B, Lalli A, Barill\u00e0 B, Budhiparama NC et al (2024) Debridement, antibiotics, and implant retention (DAIR) for the early prosthetic joint infection of total knee and hip arthroplasties: a systematic review. J ISAKOS 9(1):62\u201370. https:\/\/doi.org\/10.1016\/j.jisako.2023.09.003","journal-title":"J ISAKOS"},{"issue":"7","key":"6385_CR2","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1308\/rcsann.2023.0076","volume":"106","author":"F Awad","year":"2024","unstructured":"Awad F, Boktor J, Joseph V, Lewis MH, Silva C, Sarasin S et al (2024) Debridement, antibiotics and implant retention (DAIR) following hip and knee arthroplasty: results and findings of a multidisciplinary approach from a non-specialist prosthetic infection centre. Ann R Coll Surg Engl 106(7):633\u2013641. https:\/\/doi.org\/10.1308\/rcsann.2023.0076","journal-title":"Ann R Coll Surg Engl"},{"issue":"2","key":"6385_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5194\/jbji-10-101-2025","volume":"10","author":"IK Sigmund","year":"2025","unstructured":"Sigmund IK, Ferry T, Sousa R, Soriano A, Metsemakers WJ, Clauss M et al (2025) Debridement, antimicrobial therapy, and implant retention (DAIR) as curative strategy for acute periprosthetic hip and knee infections: a position paper of the European Bone & Joint Infection Society (EBJIS). J Bone Jt Infection 10(2):101\u2013138. https:\/\/doi.org\/10.5194\/jbji-10-101-2025","journal-title":"J Bone Jt Infection"},{"issue":"1","key":"6385_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-025-06117-z","volume":"20","author":"AA Zellner","year":"2025","unstructured":"Zellner AA, Watzlawik N, Roos J, Hischebeth GTR, Prangenberg C, Franz A et al (2025) Mid-term results after DAIR for patients with acute periprosthetic joint infections of the hip or knee. J Orthop Surg Res 20(1):676. https:\/\/doi.org\/10.1186\/s13018-025-06117-z","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"6385_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00590-025-04438-7","volume":"35","author":"LP Alamino","year":"2025","unstructured":"Alamino LP, Olaran MA, Nieto XM, Garabano G, Pesciallo C (2025) One-year success after debridement, antibiotic therapy, and implant retention for acute hip and knee periprosthetic joint infection: a retrospective cohort study of 62 patients. Eur J Orthop Surg Traumatol 35(1):316. https:\/\/doi.org\/10.1007\/s00590-025-04438-7","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"6385_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.sipas.2023.100201","volume":"14","author":"LM Gerritsen","year":"2023","unstructured":"Gerritsen LM, Scheper H, de Boer MGJ, Schoones JW, Nelissen RGHH, Pijls BGC (2023) Outcome of debridement, antibiotics and implant retention for streptococcal hip and knee prosthetic joint infections: a systematic review and meta-analysis. Surg Pract Sci 14:100201. https:\/\/doi.org\/10.1016\/j.sipas.2023.100201","journal-title":"Surg Pract Sci"},{"issue":"9","key":"6385_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12092097","volume":"12","author":"I Sancho","year":"2022","unstructured":"Sancho I, Otermin-Maya I, Guti\u00e9rrez-Dubois J, Al\u00e1ez I, Hidalgo-Ovejero \u00c1, Librero J et al (2022) Accuracy of a novel preoperative failure risk model for debridement antibiotics and implant retention (DAIR) in acute prosthetic joint infection. Diagnostics 12(9):2097. https:\/\/doi.org\/10.3390\/diagnostics12092097","journal-title":"Diagnostics"},{"issue":"8S1","key":"6385_CR8","doi-asserted-by":"publisher","first-page":"S304","DOI":"10.1016\/j.arth.2025.02.009","volume":"40","author":"EB Terhune","year":"2025","unstructured":"Terhune EB, Elmenawi KA, Grimm JA, Hannon CP, Bedard NA, Berbari EF et al (2025) Debridement, Antibiotics, and Implant Retention for Acute Periprosthetic Joint Infection: Results of 126 Primary Hip Arthroplasties at Extended Follow-Up of Seven Years. J Arthroplasty 40(8S1):S304\u2013S309. https:\/\/doi.org\/10.1016\/j.arth.2025.02.009","journal-title":"J Arthroplasty"},{"issue":"3","key":"6385_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00264-025-06422-6","volume":"49","author":"JC Perdomo-Lizarraga","year":"2025","unstructured":"Perdomo-Lizarraga JC, Combalia A, Fern\u00e1ndez-Valencia J\u00c1, Mart\u00ednez-Pastor JC, Morata L, Soriano A, Mu\u00f1oz-Mahamud E (2025) Long-term implant survival after debridement, antibiotics and implant Retention (DAIR) for acute prosthetic joint infections: is it a viable option beyond four weeks after index arthroplasty? Int Orthop 49(3):573\u2013580. https:\/\/doi.org\/10.1007\/s00264-025-06422-6","journal-title":"Int Orthop"},{"issue":"9","key":"6385_CR10","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00402-011-1291-8","volume":"131","author":"E Mu\u00f1oz-Mahamud","year":"2011","unstructured":"Mu\u00f1oz-Mahamud E, Garc\u00eda S, Bori G, Mart\u00ednez-Pastor JC, Zumbado JA, Riba J, Mensa J, Soriano A (2011) Comparison of a low-pressure and a high-pressure pulsatile lavage during d\u00e9bridement for orthopaedic implant infection. Arch Orthop Trauma Surg 131(9):1233\u20131238. https:\/\/doi.org\/10.1007\/s00402-011-1291-8","journal-title":"Arch Orthop Trauma Surg"},{"issue":"5","key":"6385_CR11","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.arth.2018.02.078","volume":"33","author":"J Parvizi","year":"2018","unstructured":"Parvizi J, Tan TL, Goswami K, Higuera C, Della Valle C, Chen AF et al (2018) The 2018 definition of periprosthetic hip and knee infection: an evidence-based and validated criteria. J Arthroplasty 33(5):1309-1314.e2. https:\/\/doi.org\/10.1016\/j.arth.2018.02.078","journal-title":"J Arthroplasty"},{"issue":"8","key":"6385_CR12","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.arth.2020.02.043","volume":"35","author":"M Wouthuyzen-Bakker","year":"2020","unstructured":"Wouthuyzen-Bakker M, L\u00f6wik CAM, Ploegmakers JJW, Knobben BAS, Dijkstra B, deVries A et al (2020) A second surgical debridement for acute periprosthetic joint infections should not be discarded. J Arthroplasty 35(8):2204\u20132209. https:\/\/doi.org\/10.1016\/j.arth.2020.02.043","journal-title":"J Arthroplasty"},{"key":"6385_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2025.07.008","author":"CC Chandler","year":"2025","unstructured":"Chandler CC, Frandsen JJ, McHugh MA, Graham SD, Fehring TK, Otero JE (2025) Outcome of Debridement, Antibiotics, and Implant Retention for Treatment of Late Acute Hematogenous Periprosthetic Joint Infections. J Arthroplasty. https:\/\/doi.org\/10.1016\/j.arth.2025.07.008","journal-title":"J Arthroplasty"},{"issue":"4","key":"6385_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.5194\/jbji-10-207-2025","volume":"10","author":"R Scholten","year":"2025","unstructured":"Scholten R, Hannink G, Somford MP, van Susante JLC (2025) The value of repeated debridement, antibiotics, and implant retention (DAIR) for early periprosthetic joint infection. J Bone Jt Infection 10(4):207\u2013215. https:\/\/doi.org\/10.5194\/jbji-10-207-2025","journal-title":"J Bone Jt Infection"},{"issue":"1","key":"6385_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.7150\/jbji.40924","volume":"5","author":"M Clauss","year":"2020","unstructured":"Clauss M, Hunkeler C, Manzoni I, Sendi P (2020) Debridement, Antibiotics and Implant Retention for Hip Periprosthetic Joint Infection: Analysis of Implant Survival after Cure of Infection. J Bone Joint Infect 5(1):35\u201342. https:\/\/doi.org\/10.7150\/jbji.40924","journal-title":"J Bone Joint Infect"},{"issue":"4","key":"6385_CR16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1302\/0301-620X.104B4.BJJ-2021-1264.R1","volume":"104-B","author":"K Veerman","year":"2022","unstructured":"Veerman K, Raessens J, Telgt D, Smulders K, Goosen JHM (2022) Debridement, antibiotics, and implant retention after revision arthroplasty\u202f: antibiotic mismatch, timing, and repeated DAIR associated with poor outcome. The Bone & Jt J 104-B(4):464\u2013471. https:\/\/doi.org\/10.1302\/0301-620X.104B4.BJJ-2021-1264.R1","journal-title":"The Bone & Jt J"},{"issue":"7","key":"6385_CR17","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1016\/j.arth.2017.02.066","volume":"32","author":"G Grammatopoulos","year":"2017","unstructured":"Grammatopoulos G, Kendrick B, McNally M, Athanasou NA, Atkins B, McLardy Smith P et al (2017) Outcome Following Debridement, Antibiotics, and Implant Retention in Hip Periprosthetic Joint Infection-An 18-Year Experience. J Arthroplasty 32(7):2248\u20132255. https:\/\/doi.org\/10.1016\/j.arth.2017.02.066","journal-title":"J Arthroplasty"},{"issue":"23","key":"6385_CR18","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.5435\/JAAOS-D-20-00939","volume":"29","author":"W Chen","year":"2021","unstructured":"Chen W, Klemt C, Smith EJ, Tirumala V, Xiong L, Kwon YM (2021) Outcomes and Risk Factors Associated With Failures of Debridement, Antibiotics, and Implant Retention in Patients With Acute Hematogenous Periprosthetic Joint Infection. J Am Acad Orthop Surg 29(23):1024\u20131030. https:\/\/doi.org\/10.5435\/JAAOS-D-20-00939","journal-title":"J Am Acad Orthop Surg"},{"issue":"1","key":"6385_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/cis966","volume":"56","author":"DR Osmon","year":"2013","unstructured":"Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM et al (2013) Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 56(1):1\u201310. https:\/\/doi.org\/10.1093\/cid\/cis966","journal-title":"Clin Infect Dis"},{"issue":"3","key":"6385_CR20","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1093\/cid\/ciz867","volume":"71","author":"CAM L\u00f6wik","year":"2020","unstructured":"L\u00f6wik CAM, Parvizi J, Jutte PC, Zijlstra WP, Knobben BAS, Xu C et al (2020) Debridement, antibiotics, and implant retention is a viable treatment option for early periprosthetic joint infection presenting more than 4 weeks after index arthroplasty. Clin Infect Dis 71(3):630\u2013636. https:\/\/doi.org\/10.1093\/cid\/ciz867","journal-title":"Clin Infect Dis"},{"issue":"1","key":"6385_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s42836-024-00282-y","volume":"6","author":"V Gupta","year":"2024","unstructured":"Gupta V, Shahban S, Petrie T, Kimani PK, Kozdryk J, Riemer B et al (2024) DAIR for periprosthetic joint infections-One week to save the joint? Arthroplasty 6(1):61. https:\/\/doi.org\/10.1186\/s42836-024-00282-y","journal-title":"Arthroplasty"},{"key":"6385_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2025.09.055","author":"MF Shannon","year":"2025","unstructured":"Shannon MF, Wong VR, Frear AJ, Bilodeau RE, Drummond E, Plate JF et al (2025) Timing of debridement, antibiotics, and implant retention within 48 hours for acute knee periprosthetic joint infection may not improve success rate. J Arthroplasty. https:\/\/doi.org\/10.1016\/j.arth.2025.09.055","journal-title":"J Arthroplasty"},{"issue":"2S","key":"6385_CR23","doi-asserted-by":"publisher","first-page":"S399","DOI":"10.1016\/j.arth.2018.09.025","volume":"34","author":"JN Argenson","year":"2019","unstructured":"Argenson JN, Arndt M, Babis G, Battenberg A, Budhiparama N, Catani F et al (2019) Hip and knee section, treatment, debridement and retention of implant: proceedings of international consensus on orthopedic infections. J Arthroplasty 34(2S):S399\u2013S419. https:\/\/doi.org\/10.1016\/j.arth.2018.09.025","journal-title":"J Arthroplasty"}],"container-title":["Archives of Orthopaedic and Trauma Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00402-026-06385-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00402-026-06385-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00402-026-06385-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T18:08:19Z","timestamp":1782238099000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00402-026-06385-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6385"],"URL":"https:\/\/doi.org\/10.1007\/s00402-026-06385-2","relation":{},"ISSN":["1434-3916"],"issn-type":[{"value":"1434-3916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"GPT-3.5 (OpenAI, San Francisco, CA, USA) was used exclusively for language editing purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI Tools use"}}],"article-number":"231"}}